Max Healthcare

In a landmark collaboration aimed at revolutionizing precision medicine, Max Healthcare Institute Ltd. has partnered with the Tata Institute for Genetics and Society (TIGS) to enhance genomic research and its application in clinical care. The partnership seeks to integrate cutting-edge genetic insights into mainstream healthcare, focusing on early disease detection, targeted treatment, and personalized medicine.

Max Healthcare Institute Ltd. has reported a 17% year-on-year increase in consolidated net profit for the first quarter, reaching Rs. 345 crore, driven by robust growth in patient volumes and operational efficiency. Revenue for the quarter rose in tandem with higher occupancy rates, improved case mix, and an uptick in premium healthcare services. The performance reflects the hospital chain’s ability to leverage its expanding network, optimize costs, and tap into rising demand for advanced medical treatments.